biote (BTMD) Competitors $6.06 -0.03 (-0.49%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BTMD vs. ADTH, DCRD, OPAL, KURA, MESO, GYRE, RCKT, CALT, ARQT, and ANIPShould you be buying biote stock or one of its competitors? The main competitors of biote include AdTheorent (ADTH), Decarbonization Plus Acquisition Co. IV (DCRD), OPAL Fuels (OPAL), Kura Oncology (KURA), Mesoblast (MESO), Gyre Therapeutics (GYRE), Rocket Pharmaceuticals (RCKT), Calliditas Therapeutics AB (publ) (CALT), Arcutis Biotherapeutics (ARQT), and ANI Pharmaceuticals (ANIP). biote vs. AdTheorent Decarbonization Plus Acquisition Co. IV OPAL Fuels Kura Oncology Mesoblast Gyre Therapeutics Rocket Pharmaceuticals Calliditas Therapeutics AB (publ) Arcutis Biotherapeutics ANI Pharmaceuticals biote (NASDAQ:BTMD) and AdTheorent (NASDAQ:ADTH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment. Is BTMD or ADTH more profitable? biote has a net margin of 5.20% compared to AdTheorent's net margin of -2.67%. AdTheorent's return on equity of 0.77% beat biote's return on equity.Company Net Margins Return on Equity Return on Assets biote5.20% -32.41% 22.26% AdTheorent -2.67%0.77%0.64% Which has more volatility & risk, BTMD or ADTH? biote has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, AdTheorent has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Do insiders and institutionals hold more shares of BTMD or ADTH? 21.7% of biote shares are held by institutional investors. Comparatively, 37.7% of AdTheorent shares are held by institutional investors. 13.9% of biote shares are held by company insiders. Comparatively, 7.1% of AdTheorent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor BTMD or ADTH? AdTheorent received 13 more outperform votes than biote when rated by MarketBeat users. However, 100.00% of users gave biote an outperform vote while only 61.90% of users gave AdTheorent an outperform vote. CompanyUnderperformOutperformbioteOutperform Votes13100.00% Underperform VotesNo VotesAdTheorentOutperform Votes2661.90% Underperform Votes1638.10% Do analysts prefer BTMD or ADTH? biote currently has a consensus target price of $8.39, indicating a potential upside of 38.41%. AdTheorent has a consensus target price of $4.69, indicating a potential upside of 46.48%. Given AdTheorent's higher possible upside, analysts plainly believe AdTheorent is more favorable than biote.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score biote 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00AdTheorent 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has preferable valuation and earnings, BTMD or ADTH? biote has higher revenue and earnings than AdTheorent. AdTheorent is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratiobiote$185.36M1.77$3.32M$0.2623.31AdTheorent$170.81M1.72$10K-$0.06-53.32 Does the media favor BTMD or ADTH? In the previous week, biote had 10 more articles in the media than AdTheorent. MarketBeat recorded 10 mentions for biote and 0 mentions for AdTheorent. biote's average media sentiment score of 0.62 beat AdTheorent's score of 0.00 indicating that biote is being referred to more favorably in the media. Company Overall Sentiment biote Positive AdTheorent Neutral Summarybiote beats AdTheorent on 13 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get biote News Delivered to You Automatically Sign up to receive the latest news and ratings for BTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTMD vs. The Competition Export to ExcelMetricbioteMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$330.19M$1.33B$5.07B$8.89BDividend YieldN/AN/A4.99%4.07%P/E Ratio23.3124.7183.5712.93Price / Sales1.778.971,220.3088.33Price / Cash12.2311.6339.4636.25Price / Book-2.592.026.936.25Net Income$3.32M-$52.95M$119.12M$225.93M7 Day Performance-7.76%-3.61%-1.83%-1.32%1 Month Performance17.21%-3.14%-3.64%0.60%1 Year Performance18.82%5.58%31.64%26.23% biote Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTMDbiote3.1909 of 5 stars$6.06-0.5%$8.39+38.4%+19.8%$330.19M$185.36M23.31194ADTHAdTheorentN/A$3.20flat$4.69+46.5%N/A$294.27M$170.81M-53.32300DCRDDecarbonization Plus Acquisition Co. IVN/AN/AN/AN/A$559.36MN/A0.002,021OPALOPAL Fuels3.4003 of 5 stars$3.67flat$7.90+115.3%-37.9%$634.26M$256.11M20.39270Positive NewsKURAKura Oncology4.082 of 5 stars$15.91-0.3%$28.83+81.2%+66.6%$1.24BN/A-6.74142Analyst ForecastMESOMesoblast1.3555 of 5 stars$10.33-4.5%$11.50+11.3%+345.3%$1.24B$5.90M0.0080Gap DownGYREGyre Therapeutics0.4926 of 5 stars$12.91-0.1%N/A-12.1%$1.21B$113.45M0.0040RCKTRocket Pharmaceuticals4.4174 of 5 stars$13.04-0.9%$51.00+291.1%-40.8%$1.20BN/A-4.74240Analyst ForecastAnalyst RevisionCALTCalliditas Therapeutics AB (publ)0.2583 of 5 stars$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180Positive NewsARQTArcutis Biotherapeutics1.7417 of 5 stars$10.18+0.9%$15.50+52.3%+391.8%$1.18B$59.61M0.00150ANIPANI Pharmaceuticals4.3361 of 5 stars$55.10-1.1%$77.33+40.4%+7.4%$1.17B$486.82M0.00642Positive News Related Companies and Tools Related Companies AdTheorent Alternatives Decarbonization Plus Acquisition Co. IV Alternatives OPAL Fuels Alternatives Kura Oncology Alternatives Mesoblast Alternatives Gyre Therapeutics Alternatives Rocket Pharmaceuticals Alternatives Calliditas Therapeutics AB (publ) Alternatives Arcutis Biotherapeutics Alternatives ANI Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BTMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTMD Stock Alerts